Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Zymeworks (ZYME) Shares Outstanding (Diluted Average) (2021 - 2025)

Zymeworks' Shares Outstanding (Diluted Average) history spans 5 years, with the latest figure at $75.4 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) fell 0.61% to $75.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $75.4 million, a 0.61% decrease, with the full-year FY2025 number at $75.4 million, down 0.61% from a year prior.
  • Shares Outstanding (Diluted Average) hit $75.4 million in Q4 2025 for Zymeworks, roughly flat from $75.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for ZYME hit a ceiling of $77.4 million in Q2 2025 and a floor of $52.1 million in Q4 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $69.1 million across 5 years, with a median of $68.5 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): rose 27.26% in 2022 and later dropped 1.34% in 2025.
  • Tracing ZYME's Shares Outstanding (Diluted Average) over 5 years: stood at $52.1 million in 2021, then rose by 25.16% to $65.2 million in 2022, then increased by 5.54% to $68.9 million in 2023, then rose by 10.19% to $75.9 million in 2024, then fell by 0.61% to $75.4 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for ZYME at $75.4 million in Q4 2025, $75.8 million in Q3 2025, and $77.4 million in Q2 2025.